George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Hazrat, exactly. I haven't read the article in question in quite a while and took what you said for granted. I was sure you were correct....so I quoted you because it saved me re-reading the paper.
MED did show benefits above placebo in the first trial but the rapid onset data needs more analysis...one of the things to look out for in the results (next week?!).
Not according to me! According to the peer reviewed publication.
A placebo is often used in blind trials. This is different from a 'placebo effect' whereby an inert substance (a placebo) can have a therapeutic effect because the patient believes they are taking a medicine that will do them good, when in fact it is inert. If medicine behaves the same as a placebo then it is difficult to argue that it is having an effect...which was the case in terms of onset time, but not in other aspects of the initial trial (duration & firmness of the erection according to Hazrat).
The latest trial has been structured to try to get data that will reduce the chance of a placebo effect (I believe).
I do not dispute what you say. My point is that placed is are usually used to check the veracity of a new drug or other medical product. Results will not always be satisfactory.
Hazrat, if I remember correctly the rapid onset time of MED was a major selling point (or FUM management made it a USP)....the potential partners pointed out that it wasn't possible to make the 'rapid onset' claim for MED with the placebo effect experienced in the initial trial. That is probably why they didn't do a deal (or a big factor).
The new trial with increased strengths of the active ingredient may provide better data to support the 'rapid onset' claim....hopefully.
Bruce, placebo effect well and truly sunk IMM's phase 3 results on Lupuzor causing the SP to crash.
Med gave harder, longer and more satisfying erections.
If you dig into the results it shows that while initially there is a placebo effect, those using med gel experienced benefits for longer and reported much greater satisfaction than those on the placebo.
Thanks for the link. Very interesting
"....There was no significant difference in onset time between MED2005 and placebo gel, probably because the gel in the 2 treatments was massaged onto the glans ***** for 15 seconds, causing sexual stimulation."
[Article Reference: J Sex Med 2018; 15: 167e175]
The increased strength of the active ingredient used in the latest trial will hopefully have results that will overcome this placebo effect. To pretend that potential partners aren't concerned about the placebo effect would be wrong in my opinion. Trial results must be a matter of days away.
I do not buy this argument. Placebos are usually used would not put off a large outfit for which the outlay would be small potatoes. Talk of the young nurse is fatuous.
Big pharma weren't interested in a partnership because of the placebo effect. If the trial results due very soon show positive results for more severe ED sufferers then potential partners would be very interested (IMO). SHouldn't be long to wait now.
The placebo effect may have something to do with having a sexy blonde nurse applying the ointment!!....unless MED includes a sexy young nurse in the retail price (male or female nurse options would be available).
Yes, I believe a very good chance of success here due to the proven absorption increasing as the dosage increased. Also the fact that original test proved a significant difference was made and that was on a lower dose.
No one really knows anything we can only all live in hope.So let’s hope this is positive news!!
So *****ing and ramping/deramping aside, does anybody have an opinion on this?
Wow